Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2023.08.09.552645

A Fit for Purpose Approach to Evaluate Detection of Amino Acid Substitutions in Shotgun Proteomics

Lundgren, T. J.·Clark, P. L.·Champion, M. M.
View original source ↗Export metadata ↓

Abstract

Amino acid substitutions (AAS) change a protein from its genome-expected sequence. Accumulation of substitutions in proteins underlie numerous diseases and antibiotic mechanisms. Accurate global detection of substitutions and their frequencies would help characterize these mechanisms. Measurement of AAS using shotgun proteomics is attractive due to its high sensitivity and untargeted acquisition. However, identifying substituted peptide-spectra requires search strategies that extrapolate beyond the genome, which can introduce bias. To characterize this bias, we constructed a "ground-truth" approach using the similarities between the Escherichia coli and Salmonella typhimurium proteomes to effectively model the complexity of distinguishing substitutions from genomic peptides. Shotgun proteomics on combined whole cell lysates from both organisms generated a library representing nearly 100,000 peptide-spectra and 4,161 distinct peptide sequences corresponding to genome-level single AAS with defined stoichiometry. We tested the ability to identify S. typhimurium peptide-spectra using only the E. coli genome in substitution-tolerant database searching. Overall, 64.1% of library peptides were correctly identified. We observed a wide range of identification efficiencies based on the specific AAS, but no inherent bias from stoichiometry of the substitution. Short peptides and substitutions near peptide termini, which require specific diagnostic ions for unambiguous identification, are matched with below-average frequency. We also identified "scissor substitutions" that gain or lose protease cleavage sites. Although scissor substitutions are chemically distinct from the genomic peptide, they had poor identification efficiency. This ground-truth AAS library identifies multiple sources of bias in AAS peptide-spectra identification and sets expectations for the application of shotgun proteomics to testing AAS hypotheses. Significance statementHigh-fidelity decoding of the genome is essential for life. Mistranslation leads to amino acid substitutions, which can disrupt protein folding and function, and impact cell fitness. Detection of mistranslated protein products necessitates robust and non-biased approaches. Proteomics is a promising solution, but identifying non-genomic peptide-spectra is a severe bioinformatics challenge. We created a ground-truth library of substituted amino acid peptides by mixing two closely related bacteria in a single sample. We quantitatively defined the degree to which informatics could correctly distinguish substituted peptides when single-organism databases are present. This approach defines intrinsic and informatics limits in substitution detection in shotgun proteomics and identifies previously overlooked challenges with identifying "scissor substitutions".

Source connections

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Lundgren, T. J., Clark, P. L., Champion, M. M.. 2023-08-13. A Fit for Purpose Approach to Evaluate Detection of Amino Acid Substitutions in Shotgun Proteomics. https://doi.org/10.1101/2023.08.09.552645

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

mFrag: Integrating External DNA Methylation References Improves Lung Cancer Early Detection by Fragmentomics

Fragmentomics analyzes features of circulating cell-free DNA fragments (e.g., fragment length or end motifs) derived from whole-genome sequencing of liquid biopsy samples (blood or other body fluids), enabling non-invasive early cancer detection. Here we present mFrag, a framework that integrates external methylation reference atlases with fragmentomic features for lung cancer detection. mFrag comprises two complementary methods: mFrag-Weight, which uses DNA methylation information to weight fragmentomic features, and mFrag-Net, which integrates fragmentomic features and external DNA methylation data through neural networks. We average the output probabilities of the two methods to obtain a final prediction score. The mFrag model was trained using 287 individuals at risk for lung cancer. In an independent case-control testing set comprising 385 non-cancer controls and 46 cancers (28 stage I, 12 stage II, and 6 stage III or IV), mFrag outperforms a DELFI-style fragmentomic approach, improving PR-AUC from 0.455 to 0.720 and sensitivity at 99% specificity from 0.043 to 0.478, with ROC-AUC from 0.871 to 0.908. For stage I lung cancer, mFrag raises PR-AUC from 0.314 to 0.558 and ROC-AUC from 0.855 to 0.894. Applied to end 4-mer motif features, mFrag likewise improved over an unweighted baseline, with gains contributed by both mFrag-Weight and mFrag-Net. In summary, mFrag improves the accuracy of fragmentomics-based lung cancer detection through integrating external DNA methylation data and the complementarity of its two component models, without incurring any additional data-generating cost.

bioinformatics↗
bioRxiv2026

AOPTK: Open-Source Software for AI-Assisted Toxicological Literature Analysis

Motivation: Toxicologists today face a challenge: although vast amounts of data describing how chemicals affect human health are available across scientific publications and regulatory reports, much of this information remains underutilized because extracting and interpreting evidence across thousands of studies is impractical to perform manually. Recent advances in artificial intelligence (AI), particularly in large language models (LLMs), provide new opportunities to automate toxicological literature analysis. Results: Herein, we present the Adverse Outcome Pathway Toolkit (AOPTK), an open-source Python package for AI-enhanced analysis of toxicological and biomedical literature. AOPTK supports (i) automated literature retrieval from databases such as PubMed Central and Europe PMC, (ii) direct processing of full-text articles in PDF format, and (iii) LLM-assisted analysis tools to identify chemicals and extract their relationships to biological effects under user-defined conditions. We demonstrate its utilities through a case-study identifying potential non-genotoxic carcinogens based on their ability to inhibit gap junction intercellular communication (GJIC). The LLM-enhanced analysis achieves 81% agreement with an expert-curated inhibitor list and 95% accuracy in predicting inhibition versus no inhibition when analysing the same subset of 86 publications. Automated retrieval and analysis of 1 124 publications from PubMed Central further demonstrated the feasibility of applying AOPTK to large-scale literature analyses. Availability: The package is developed open source on GitHub, disseminated through PyPI and Bioconda and releases are archived on Zenodo. Individual tools are available in the Galaxy platform for accessible data analysis with user-friendly, findable, accessible, interoperable, and reusable (FAIR) and end-to-end workflows provided via WorkflowHub. The tools are available on usegalaxy.eu and usegalaxy.cz and are developed open source on GitHub.

bioinformatics↗
bioRxiv2026

MELD: Mutation Effect Learning through Differential embeddings

We introduce MELD (Mutation Effect Learning through Differential Embeddings), a compact model for predicting the functional consequences of single nucleotide variants (SNVs) by training directly on the wild-type (WT) versus mutant differential. Interpreting SNVs is central to clinical genomics, yet experimental characterization cannot scale to millions of observed variants. Leading sequence-to-function models (Enformer, Borzoi, AlphaGenome) are trained on absolute genomic tracks and score variants post hoc through in-silico mutagenesis (ISM), so the WT-mutant difference never enters the training loss. MELD instead places the logit difference {Delta}z = zmut - zwt inside the supervised objective. It combines a shared CNN-Transformer encoder, a mutant-specific mutation-mask boost, multiscale mutation-centered pooling, and a learned adaptive amplification factor . On ClinVar (1.57M variants), MELD (1.9M parameters) reached an AUROC of 0.986 versus 0.800 for a same-data, same-backbone ISM baseline, with ablations confirming the contribution of each component. On a shared benchmark, it outperformed frozen foundation models with 3-1,300x more parameters (AUROC 0.967 vs. 0.924 for AlphaGenome and 0.936 for Nucleotide Transformer). With only 50, 000 training variants, it exceeded the ISM baseline trained on all 1.48M (AUROC 0.903 vs. 0.796) variants. On BRCA1 saturation genome editing, frozen MELD achieved a Spearman {rho} of 0.42, above Borzoi (0.40), and ClinVar transfer raised it to 0.45. These results demonstrate that direct differential supervision is a compact, data-efficient alternative to post-hoc ISM scoring with substantially larger pretrained models.

bioinformatics↗